INMB
INmune Bio Inc
2.00$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9,916.3% | -12,146.4% | -53,400.0% | – | – | – | -13,648.0% | – | – | – | – | – | – | |
| – | – | 242.9% | – | – | – | 0.0% | – | – | – | – | – | – | |
| 4,393.0% | 6,710.7% | 12,707.1% | – | – | – | 4,152.0% | – | – | – | – | – | – | |
| 5,479.1% | 11,010.7% | 12,400.0% | – | – | – | 1,678.0% | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | |
| -5,932.6% | 9,110.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.0% | – | – | – | – | – | – | |
| -4,011.6% | -8,928.6% | -17,857.1% | – | – | – | 10,548.0% | – | – | – | – | – | – | |
| -13,981.4% | -21,303.6% | -70,328.6% | – | – | – | -3,170.0% | – | – | – | – | – | – | |
| -9,916.3% | -12,146.4% | -53,400.0% | – | – | – | -13,648.0% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.